We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
(+7.2%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
8.12%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,821
Reduced
816
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$89.1M |
| 2 |
WEX
WEX
|
+$78.4M |
| 3 |
Blackrock
BLK
|
+$73.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$71.9M |
| 5 |
OneMain Financial
OMF
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$63.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$56.6M |
| 3 |
Agnico Eagle Mines
AEM
|
+$55.1M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$36M |
| 5 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
VanEck Gold Miners ETF
GDX
$25.6B
| $9.33M | 0.05% |
316,754
+9,444
| +3% | +$308K |
|
327
Mistras Group
MG
$498M
| $9.33M | 0.05% |
918,256
+886
| +0.1% | +$8.74K |
|
328
Allstate
ALL
$70.8B
| $9.32M | 0.05% |
73,188
+3,388
| +5% | +$448K |
|
329
iShares Russell Mid-Cap Value ETF
IWS
$15.8B
| $9.3M | 0.05% |
82,112
+6,383
| +8% | +$739K |
|
330
ConocoPhillips
COP
$142B
| $9.21M | 0.05% |
135,874
-36,446
| -21% | -$2.1M |
|
331
Toronto Dominion Bank
TD
$200B
| $9.14M | 0.05% |
138,216
-33
| -0% | -$2.2K |
|
332
Wynn Resorts
WYNN
$10.5B
| $9.11M | 0.05% |
107,487
+58,316
| +119% | +$5.76M |
|
333
Invesco Variable Rate Preferred ETF
VRP
$3.01B
| $9.04M | 0.05% |
344,603
+17,499
| +5% | +$461K |
|
334
Brookfield Renewable
BEP
$9.82B
| $9.03M | 0.05% |
244,688
+41,831
| +21% | +$1.62M |
|
335
Otis Worldwide
OTIS
$28.1B
| $8.99M | 0.05% |
109,295
+5,202
| +5% | +$457K |
|
336
MetLife
MET
$64.3B
| $8.92M | 0.05% |
144,511
+11,801
| +9% | +$710K |
|
337
FedEx
FDX
$74.7B
| $8.89M | 0.05% |
40,562
+21,579
| +114% | +$5.86M |
|
338
FlexShares iBoxx 5-Year Target Duration TIPS Index Fund
TDTF
$1.04B
| $8.87M | 0.05% |
317,451
+53,749
| +20% | +$1.51M |
|
339
Travelers Companies
TRV
$80.5B
| $8.84M | 0.05% |
58,164
+9,137
| +19% | +$1.41M |
|
340
Unilever
UL
$137B
| $8.84M | 0.05% |
144,924
-26,884
| -16% | -$1.71M |
|
341
Camden Property Trust
CPT
$11B
| $8.84M | 0.05% |
59,941
+28,854
| +93% | +$4.23M |
|
342
Moderna
MRNA
$21.5B
| $8.65M | 0.05% |
22,484
+3,043
| +16% | +$1.12M |
|
343
Vanguard Total International Bond ETF
BNDX
$82.1B
| $8.52M | 0.04% |
149,519
+32,285
| +28% | +$1.86M |
|
344
First Trust Value Line Dividend Fund
FVD
$8.38B
| $8.45M | 0.04% |
215,672
-11,217
| -5% | -$455K |
|
345
Ecolab
ECL
$79.8B
| $8.42M | 0.04% |
40,351
-867
| -2% | -$190K |
|
346
Republic Services
RSG
$64.5B
| $8.34M | 0.04% |
69,503
+22,552
| +48% | +$2.7M |
|
347
Lam Research
LRCX
$383B
| $8.33M | 0.04% |
146,300
+9,690
| +7% | +$589K |
|
348
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.46B
| $8.24M | 0.04% |
109,405
+93,136
| +572% | +$7.23M |
|
349
Occidental Petroleum
OXY
$55.7B
| $8.22M | 0.04% |
277,840
-1,128
| -0.4% | -$30.1K |
|
350
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
| $8.21M | 0.04% |
17,083
-228
| -1% | -$112K |
|
Similar funds
NAMI
Rockefeller Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,821 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.
- Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
- Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
- Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
- Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
- Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
- Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.
Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.